Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole + Sodium Bicarbonate vs Nexium in GERD
NCT01471925Phase 3Withdrawn
- Sponsor
- Eurofarma
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole + sodium bicarbonate in gastroesophageal reflux disease (GERD), sponsored by Eurofarma. Status: withdrawn.
02
Drugs
esomeprazole + sodium bicarbonate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01471925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471925.